The Use of Non-Invasive Brain Stimulation for the Management of Chronic Musculoskeletal Pain: Fad or Future?
- PMID: 40722350
- PMCID: PMC12293623
- DOI: 10.3390/brainsci15070760
The Use of Non-Invasive Brain Stimulation for the Management of Chronic Musculoskeletal Pain: Fad or Future?
Abstract
This article aims to offer a broad perspective on the use of non-invasive brain stimulation (NIBS) techniques in the context of chronic musculoskeletal pain (CMP) conditions. While NIBS has demonstrated promising efficacy in certain chronic pain populations, its application in the management of CMP remains limited. This paper examines the current evidence supporting the use of NIBS for pain relief in CMP, the rationale and proposed mechanisms of action, the importance of patient selection, common methodological limitations in the existing literature, and the potential adverse effects of these techniques. The authors argue that the current evidence is insufficient to support widespread clinical adoption of NIBS for CMP. Advancing the field will require more rigorous study designs, with adequately powered and properly blinded randomized controlled trials. Additionally, future research should address the identification of potential responders to brain stimulation, conduct economic evaluations, and carefully assess the benefit-risk ratio before NIBS can be integrated into routine clinical practice.
Keywords: brain stimulation; chronic musculoskeletal pain; review.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
What is the value of routinely testing full blood count, electrolytes and urea, and pulmonary function tests before elective surgery in patients with no apparent clinical indication and in subgroups of patients with common comorbidities: a systematic review of the clinical and cost-effective literature.Health Technol Assess. 2012 Dec;16(50):i-xvi, 1-159. doi: 10.3310/hta16500. Health Technol Assess. 2012. PMID: 23302507 Free PMC article.
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Analgesic effects of noninvasive brain stimulation in rodent animal models: a systematic review of translational findings.Neuromodulation. 2012 Jul;15(4):283-95. doi: 10.1111/j.1525-1403.2012.00478.x. Epub 2012 Jul 3. Neuromodulation. 2012. PMID: 22759345 Free PMC article.
-
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948. Health Technol Assess. 2024. PMID: 39367772 Free PMC article.
-
The effect of financial incentives on the quality of health care provided by primary care physicians.Cochrane Database Syst Rev. 2011 Sep 7;(9):CD008451. doi: 10.1002/14651858.CD008451.pub2. Cochrane Database Syst Rev. 2011. PMID: 21901722
References
-
- Lefaucheur J.P., André-Obadia N., Antal A., Ayache S.S., Baeken C., Benninger D.H., Cantello R.M., Cincotta M., de Carvalho M., De Ridder D., et al. Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS) Clin. Neurophysiol. 2014;125:2150–2206. doi: 10.1016/j.clinph.2014.05.021. - DOI - PubMed
-
- Hyde J., Carr H., Kelley N., Seneviratne R., Reed C., Parlatini V., Garner M., Solmi M., Rosson S., Cortese S., et al. Efficacy of neurostimulation across mental disorders: Systematic review and meta-analysis of 208 randomized controlled trials. Mol. Psychiatry. 2022;27:2709–2719. doi: 10.1038/s41380-022-01524-8. - DOI - PMC - PubMed
-
- U.S. Food & Drug Administration [(accessed on 1 June 2025)];Repetitive Transcranial Magnetic Stimulation (rTMS) Systems—Class II Special Controls Guidance for Industry and FDA Staff 2011. Available online: https://www.fda.gov/medical-devices/guidance-documents-medical-devices-a....
LinkOut - more resources
Full Text Sources